Vonozan Tablets

Vonozan Tablets – High-Efficacy P-CAB Therapy

Vonozan is utilized for the management of serious acid-related gastrointestinal disorders, including reflux esophagitis and peptic ulcers. It is specifically designed to provide strong and sustained acid suppression, which is vital for the healing of erosive tissues in the esophagus. The medication is also indicated for the prevention of gastric or duodenal ulcers in at-risk patients taking chronic NSAIDs or low-dose aspirin. Clinically, it is a key part of the regimen used to treat stomach infections caused by H. pylori bacteria, even in settings of complex gastric pathologies. Its mechanism as a potassium-competitive acid blocker ensures that stomach acid production is significantly reduced from the first dose. This leads to rapid symptom relief for patients suffering from persistent heartburn and acid regurgitation. The once-daily tablet is well-tolerated and provides effective 24-hour control over gastric acidity.

• Indicated for gastric/duodenal ulcers and reflux esophagitis.
• Supports H. pylori eradication in various clinical settings.
• Provides rapid and sustained reduction of stomach acid.
• Available as: Tablets 10MG and 20MG.